Norges Bank
SRNE

Norges Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Norges Bank’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,125,259
Closed -$2.77M – 2196
2022
Q4 		$2.77M Buy
3,125,259
+223,776
+8% +$297K ﹤0.01% 1924
2022
Q3 		$4.56M Hold
2,901,483
– – ﹤0.01% 1785
2022
Q2 		$5.83M Buy
2,901,483
+717,900
+33% +$1.24M ﹤0.01% 1732
2022
Q1 		$5.09M Buy
2,183,583
+1,255,291
+135% +$3.92M ﹤0.01% 1867
2021
Q4 		$4.32M Buy
928,292
+215,757
+30% +$1.34M ﹤0.01% 1929
2021
Q3 		$5.44M Buy
+712,535
New +$6.04M ﹤0.01% 1913

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Norges Bank's SRNE Position: Q1 2023 in Review

Norges Bank sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 3,125,259 shares — an estimated $2.77M sold.

Norges Bank first reported a position in SRNE in Q3 2021 and held it in 6 quarters. The position peaked at $5.83M in Q2 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Norges Bank reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Norges Bank sold 3,125,259 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $2.77M.
  • Norges Bank first reported a position in Sorrento Therapeutics, Inc. in Q3 2021 and held it in 6 quarters.
  • Norges Bank's Sorrento Therapeutics, Inc. position peaked at $5.83M in Q2 2022.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Norges Bank's 13F filing for Q1 2023, filed 15 May 2023.